Anavex Life Sciences Corp. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AVXL Nasdaq 2836 www.anavex.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anavex Life Sciences Corp.

Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors - Nov 3rd, 2026 5:00 am
Aevex stock drops 5% as US Navy halts $130M drone boat program - Oct 21st, 2026 5:41 am
Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies - Oct 20th, 2026 2:00 pm
Anavex Receives FDA IND Clearance for Blarcamesine in Fragile X Syndrome, Enabling Phase 2a Trial - Oct 16th, 2026 7:33 am
Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome - Oct 15th, 2026 2:00 pm
Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting - Sep 24th, 2026 8:00 am
PVG Asset Management Announces Plan for First 100 Days at Anavex Life Sciences - Sep 18th, 2026 7:48 am
Glass Lewis Recommends Anavex Stockholders Vote the GOLD Universal Proxy Card, Citing “Functionally Inert Stewardship” in Support of PVG Asset Management’s Call for Change - Sep 17th, 2026 10:17 am
PVG Asset Management Believes ISS Acknowledges Anavex’s Repeated Missteps, Failed Board Oversight, Lack of Director Stock Ownership, and AVXL Stock Price Underperformance - Sep 14th, 2026 5:30 pm
Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote “FOR” All Six of Anavex’s Highly Qualified Director Nominees - Sep 14th, 2026 6:30 am
PVG Asset Management to Host Investor Call Regarding Anavex Life Sciences Proxy Campaign - Sep 10th, 2026 12:45 pm
PVG Asset Management Issues Important Information About Anavex Life Sciences (AVXL) - Sep 9th, 2026 7:53 am
Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET - Sep 8th, 2026 6:00 am
PVG Sends Open Letter to Anavex Stockholders Detailing the Need for Change at the Company - Sep 3rd, 2026 3:46 pm
Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement - Sep 2nd, 2026 2:00 pm
PVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.’s 2026 Annual Meeting - Sep 1st, 2026 3:35 pm
Sector Update: Healthcare Stocks Advance Late Afternoon - Aug 25th, 2026 1:57 pm
Anavex Life Sciences Advances Alzheimer’s Phase 3 Planning as Cash Runway Extends Into Fiscal 2028 - Aug 25th, 2026 8:46 am
Anavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update - Aug 25th, 2026 6:00 am
Real Parkinson’s Disease Hope from Jupiter Neurosciences - Aug 19th, 2026 10:32 am